等待開盤 12-17 09:30:00 美东时间
+0.090
+1.68%
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
11-14 10:43
DA Davidson analyst Peter Heckmann maintains PaySign (NASDAQ:PAYS) with a Buy and maintains $9 price target.
11-13 22:51
PaySign (NASDAQ:PAYS) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.02 by 81.82 percent. This is a 33.33 percent increase over earnings of $0.03 per share from the same
11-13 05:08
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
11-12 19:11
COLUMBIA, Maryland , Oct. 30, 2025 /PRNewswire/ -- The Mexico Fund, Inc. (NYSE: MXF) announced that it will pay today a distribution of $0.25 per share in cash to stockholders of record as ...
10-30 21:00
As of Oct. 1, 2025, two stocks in the financial sector could be flashing a real...
10-01 21:01
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries,
09-15 20:06
3 software stocks, Intrusion, Katapult, & PaySign, surge in momentum rankings, signaling strong price performance in the sector.
09-04 20:42
今日重点评级关注:韦德布什:维持Gossamer Bio"跑赢大市"评级,目标价从4美元升至5美元;HC Wainwright & Co.:维持EyePoint Pharmaceuticals"买入"评级,目标价从22美元升至23美元
08-07 09:46
Lake Street analyst Jacob Stephan maintains PaySign (NASDAQ:PAYS) with a Buy and raises the price target from $9 to $10.
08-07 03:58